173 related articles for article (PubMed ID: 22391529)
1. L-selectin and P-selectin are novel biomarkers of cervicovaginal inflammation for preclinical mucosal safety assessment of anti-HIV-1 microbicide.
Zhong M; He B; Yang J; Bao R; Zhang Y; Zhou D; Chen Y; Li L; Han C; Yang Y; Sun Y; Cao Y; Li Y; Shi W; Jiang S; Zhang X; Yan H
Antimicrob Agents Chemother; 2012 Jun; 56(6):3121-32. PubMed ID: 22391529
[TBL] [Abstract][Full Text] [Related]
2. New candidate biomarkers in the female genital tract to evaluate microbicide toxicity.
Fields S; Song B; Rasoul B; Fong J; Works MG; Shew K; Yiu Y; Mirsalis J; D'Andrea A
PLoS One; 2014; 9(10):e110980. PubMed ID: 25333937
[TBL] [Abstract][Full Text] [Related]
3. A quantitative multiplex nuclease protection assay reveals immunotoxicity gene expression profiles in the rabbit model for vaginal drug safety evaluation.
Fichorova RN; Mendonca K; Yamamoto HS; Murray R; Chandra N; Doncel GF
Toxicol Appl Pharmacol; 2015 Jun; 285(3):198-206. PubMed ID: 25818602
[TBL] [Abstract][Full Text] [Related]
4. Preclinical assessment of the proinflammatory potential of microbicide candidates.
Doncel GF; Chandra N; Fichorova RN
J Acquir Immune Defic Syndr; 2004 Oct; 37 Suppl 3():S174-80. PubMed ID: 16419269
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of cervicovaginal inflammation for the assessment of microbicide safety.
Cummins JE; Doncel GF
Sex Transm Dis; 2009 Mar; 36(3 Suppl):S84-91. PubMed ID: 19218890
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety.
Wilson SS; Cheshenko N; Fakioglu E; Mesquita PM; Keller MJ; Herold BC
Antivir Ther; 2009; 14(8):1113-24. PubMed ID: 20032541
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of leukocyte traffic and activation in the vaginal mucosa.
Trifonova RT; Bajpai M; Pasicznyk JM; Chandra N; Doncel GF; Fichorova RN
Biomarkers; 2007; 12(6):608-22. PubMed ID: 17852080
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel.
Keller MJ; Madan RP; Torres NM; Fazzari MJ; Cho S; Kalyoussef S; Shust G; Mesquita PM; Louissaint N; Chen J; Cohen HW; Diament EC; Lee AC; Soto-Torres L; Hendrix CW; Herold BC
PLoS One; 2011 Jan; 6(1):e16475. PubMed ID: 21283552
[TBL] [Abstract][Full Text] [Related]
9. Increased CCL2 expression and macrophage/monocyte migration during microbicide-induced vaginal irritation.
Alt C; Harrison T; Dousman L; Fujita N; Shew K; Tran TT; Shayesteh S; Matsukawa A; Mirsalis J; D'Andrea A
Curr HIV Res; 2009 Nov; 7(6):639-49. PubMed ID: 19929801
[TBL] [Abstract][Full Text] [Related]
10. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives.
Fichorova RN; Bajpai M; Chandra N; Hsiu JG; Spangler M; Ratnam V; Doncel GF
Biol Reprod; 2004 Sep; 71(3):761-9. PubMed ID: 15128598
[TBL] [Abstract][Full Text] [Related]
11. Guiding the vaginal microbicide trials with biomarkers of inflammation.
Fichorova RN
J Acquir Immune Defic Syndr; 2004 Oct; 37 Suppl 3(Suppl 3):S184-93. PubMed ID: 16419271
[TBL] [Abstract][Full Text] [Related]
12. Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates.
Zalenskaya IA; Joseph T; Bavarva J; Yousefieh N; Jackson SS; Fashemi T; Yamamoto HS; Settlage R; Fichorova RN; Doncel GF
PLoS One; 2015; 10(6):e0128557. PubMed ID: 26052926
[TBL] [Abstract][Full Text] [Related]
13. Topical microbicides for prevention of sexually transmitted infections.
Obiero J; Mwethera PG; Wiysonge CS
Cochrane Database Syst Rev; 2012 Jun; (6):CD007961. PubMed ID: 22696373
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides.
Gali Y; Delezay O; Brouwers J; Addad N; Augustijns P; Bourlet T; Hamzeh-Cognasse H; Ariën KK; Pozzetto B; Vanham G
Antimicrob Agents Chemother; 2010 Dec; 54(12):5105-14. PubMed ID: 20921308
[TBL] [Abstract][Full Text] [Related]
15. Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failure.
Mauck CK; Lai JJ; Weiner DH; Chandra N; Fichorova RN; Dezzutti CS; Hillier SL; Archer DF; Creinin MD; Schwartz JL; Callahan MM; Doncel GF
AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1475-86. PubMed ID: 23885658
[TBL] [Abstract][Full Text] [Related]
16. Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.
Trifonova RT; Pasicznyk JM; Fichorova RN
Antimicrob Agents Chemother; 2006 Dec; 50(12):4005-10. PubMed ID: 17030562
[TBL] [Abstract][Full Text] [Related]
17. Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides.
Catalone BJ; Kish-Catalone TM; Budgeon LR; Neely EB; Ferguson M; Krebs FC; Howett MK; Labib M; Rando R; Wigdahl B
Antimicrob Agents Chemother; 2004 May; 48(5):1837-47. PubMed ID: 15105142
[TBL] [Abstract][Full Text] [Related]
18. Effects of tenofovir on cytokines and nucleotidases in HIV-1 target cells and the mucosal tissue environment in the female reproductive tract.
Biswas N; Rodriguez-Garcia M; Shen Z; Crist SG; Bodwell JE; Fahey JV; Wira CR
Antimicrob Agents Chemother; 2014 Nov; 58(11):6444-53. PubMed ID: 25136003
[TBL] [Abstract][Full Text] [Related]
19. High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicides.
Vincent KL; Bourne N; Bell BA; Vargas G; Tan A; Cowan D; Stanberry LR; Rosenthal SL; Motamedi M
Sex Transm Dis; 2009 May; 36(5):312-8. PubMed ID: 19295469
[TBL] [Abstract][Full Text] [Related]
20. Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety.
Mesquita PM; Cheshenko N; Wilson SS; Mhatre M; Guzman E; Fakioglu E; Keller MJ; Herold BC
J Infect Dis; 2009 Aug; 200(4):599-608. PubMed ID: 19586414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
